ViralCure

Rebuilding The Funding Layer For Scientific Research

ViralCure set out to address a structural problem in scientific research: promising projects often move slowly, or do not get funded at all, because capital allocation depends on opaque review cycles, institutional gatekeepers, and fragmented administrative processes.

The team wanted to test a different model. Instead of relying only on traditional grant programs, they envisioned a blockchain-enabled funding platform where research initiatives could be presented more transparently, contributors could understand how funds were being allocated, and the supporting infrastructure could scale into a broader DeSci ecosystem over time.

The Product Direction

The platform was designed around a simple premise: research teams should be able to present initiatives, define funding needs, and manage the lifecycle of those opportunities in a system where transactions and governance actions are easier to audit.

That required more than a token layer. ViralCure needed a usable product stack that combined on-chain logic with an accessible application layer: contributor-facing flows, project publication mechanics, and interfaces that made a technically complex model understandable to non-crypto-native users.

The Engineering Challenge

The core challenge was translating an ambitious DeSci concept into a credible MVP. The system needed to support transparent project creation, funding mechanics, and a governance-oriented structure without overwhelming users with blockchain complexity.

That meant solving across multiple layers at once:

• designing the product architecture for an early-stage platform with evolving requirements
• defining which actions belonged on-chain and which should remain in the application layer
• building user-facing workflows that made scientific funding feel legible rather than experimental
• creating a foundation that could later expand into marketplace and tokenized-IP components

Rather Labs' Role

Rather Labs worked as the engineering partner responsible for shaping the platform into an executable product roadmap and delivering the technical foundation for the first version of the system.

Our role covered both blockchain and product engineering. On the Web3 side, we helped define the mechanics needed to support transparent funding flows and future tokenized research primitives. On the application side, we contributed to the institutional website, product structure, and dApp components needed to turn the concept into something users could actually interact with.

Solution

The solution was structured as a staged product build rather than a single monolithic release. Rather Labs helped ViralCure assemble the core platform pieces required to validate the concept:

• a foundation for blockchain-backed funding workflows
• a starter dApp to support fundraising setup and project management
• a marketplace-oriented product direction for exploring tokenized scientific assets
• the institutional web presence needed to explain the model and onboard early users

This approach preserved momentum while keeping the architecture flexible. Instead of overcommitting to a rigid protocol too early, the product could evolve based on user adoption, ecosystem feedback, and regulatory considerations that are especially important in health- and science-adjacent domains.

Why This Matters

What made ViralCure interesting was not just the use of blockchain, but the fit between the technology and the problem. Research funding is fundamentally a coordination challenge: capital, trust, visibility, and accountability all need to align across many stakeholders. Blockchain does not solve the scientific problem itself, but it can improve how funding decisions and resource flows are recorded, distributed, and inspected.

For Rather Labs, the project was a strong example of what early DeSci product engineering actually looks like in practice: not hype-driven tokenization, but careful translation of a difficult coordination problem into product, protocol, and infrastructure decisions that can be tested in the real world.